- Investing Ideas
- Belgian Pharmaceuticals & Biotech Stable Growth Stocks
Belgian Pharmaceuticals & Biotech Stable Growth Stocks
Results
2
0 new
2 companies
UCB
Market Cap: €50.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€264.40
7D
5.0%
1Y
60.4%
argenx
Market Cap: €47.4b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€763.00
7D
9.7%
1Y
50.7%